Rapid urinary trypsinogen-2 test strip in the diagnosis of pancreatitis after endoscopic retrograde cholangiopancreatography

Pancreas

Volumn 40, Issue 8, 2011, Pages 1211-1214

  Tseng, Chih Wei ^a,b   Chen, Chun Chia ^b,c   Lin, Shan Zu ^c   Chang, Full Young ^b,c   Lin, Han Chieh ^b,c   Lee, Shou Dong ^b,c  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

endoscopic retrograde cholangiopancreatography; pancreatitis; strip test; urinary trypsinogen 2

Indexed keywords

AMYLASE; TRIACYLGLYCEROL LIPASE; TRYPSINOGEN; TRYPSINOGEN 2; UNCLASSIFIED DRUG;

ADULT; AGED; AMYLASE BLOOD LEVEL; CONFERENCE PAPER; CONTROLLED STUDY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PANCREATITIS; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RAPID URINARY TRYPSINOGEN 2 TEST STRIP; SENSITIVITY AND SPECIFICITY; TRIACYLGLYCEROL LIPASE BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; AMYLASES; BIOLOGICAL MARKERS; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; EARLY DIAGNOSIS; FEMALE; HUMANS; LIPASE; MALE; MIDDLE AGED; PANCREATITIS; PREDICTIVE VALUE OF TESTS; TIME FACTORS; TRYPSIN; TRYPSINOGEN;

EID: 80054850047     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0b013e31821fcdcf     Document Type: Conference Paper

References (26)

1. Sahni VA, Mortele KJ. Magnetic resonance cholangiopancreatography: Current use and future applications. Clin Gastroenterol Hepatol. 2008;6:967-977.
2. Andriulli A, Loperfido S, Napolitano G, et al. Incidence rates of post-ERCP complications: A systematic survey of prospective studies. Am J Gastroenterol. 2007;102:1781-1788.
3. Gottlieb K, Sherman S, Pezzi J, et al. Early recognition of post-ERCP pancreatitis by clinical assessment and serum pancreatic enzymes. Am J Gastroenterol. 1996;91:1553-1557.
4. Testoni PA, Bagnolo F, Caporuscio S, et al. Serum amylase measured four hours after endoscopic sphincterotomy is a reliable predictor of postprocedure pancreatitis. Am J Gastroenterol. 1999;94:1235-1241.
5. Ito K, Fujita N, Noda Y, et al. Relationship between post-ERCP pancreatitis and the change of serum amylase level after the procedure. World J Gastroenterol. 2007;13:3855-3860.
6. Chen CC, Wang SS, Lu RH, et al. The early changes of serum proinflammatory and anti-inflammatory cytokines after endoscopic retrograde cholangiopancreatography. Pancreas. 2003;26:375-380.
7. Itkonen O, Koivunen E, Hurme M, et al. Time-resolved immunofluorometric assays for trypsinogen-1 and 2 in serum reveal preferential elevation of trypsinogen-2 in pancreatitis. J Lab Clin Med. 1990;115:712-718.
8. Figarella C, Amouric M, Guy-Crotte O. Enzyme activation and liberation: Intracellular/extracellular events. In: Beger HG, Buchler M, eds. Acute Pancreatitis: Research and Clinical Management. Berlin, Germany: Springer; 1987:53-60.
9. Hedström J, Korvuo A, Kenkimäki P, et al. Urinary trypsinogen-2 test strip for acute pancreatitis. Lancet. 1996;347:729-730.
10. Kemppainen EA, Hedström JI, Puolakkainen PA, et al. Rapid measurement of urinary trypsinogen-2 as a screening test for acute pancreatitis. N Engl J Med. 1997;336:1788-1793.
11. Chen YT, Chen CC, Wang SS, et al. Rapid urinary trypsinogen-2 test strip in the diagnosis of acute pancreatitis. Pancreas. 2005;30:243-247.
12. Lempinen M, Stenman U-H, Finne P, et al. Trypsinogen-2 and trypsinogen activation peptide (TAP) in urine of patients with acute pancreatitis. J Surg Res. 2003;111:267-273.
13. Cotton PB, eLhman G, Vennes AJ, et al. Endoscopic sphincterotomy complications and their management: An attempt at consensus. Gastrointest Endosc. 1991;37:383-391.
14. Ransohoff DF, Feinstein AR. Problems of spectrum and bias in evaluating the efficacy of diagnostic tests. N Engl J Med. 1978;299: 926-930.
15. Cotton PB, Garrow DA, Gallagher J, et al. Risk factors for complications after ERCP: A multivariate analysis of 11,497 procedures over 12 years. Gastrointest Endosc. 2009;70:80-88.
16. Wang P, Li ZS, Liu F, et al. Risk factors for ERCP-related complications: A prospective multicenter study. Am J Gastroenterol. 2009;104:31-40.
17. Badalov N, Tenner S, Baillie J. The Prevention, recognition and treatment of post-ERCP pancreatitis. JOP. 2009;10:88-97.
18. Sultan S, Baillie J. What are the predictors of post-ERCP pancreatitis, and how useful are they? JOP. 2002;3:188-194.
19. Chen CC, Wang SS, Lee FY, et al. Proinflammatory cytokines in early assessment of the prognosis of acute pancreatitis. Am J Gastroenterol. 1999;94:213-218.
20. Al-Bahrani AZ, Ammori BJ. Clinical laboratory assessment of acute pancreatitis. Clin Chim Acta. 2005;362:26-48.
21. Kemppainen E, Hedstrom J, Puolakkainen P, et al. Increased serum trypsinogen 2 and trypsin 2-alpha 1 antitrypsin complex values identify endoscopic retrograde cholangiopancreatography induced pancreatitis with high accuracy. Gut. 1997;41:690-695.
22. Kemppainen E, Hedstrom J, Puolakkainen P, et al. Urinary trypsinogen-2 test strip in detecting ERCP-induced pancreatitis. Endoscopy. 1997;29:247-251.
23. Sankaralingam S, Wesen C, Barawi M, et al. Use of the urinary trypsinogen-2 dip stick test in early diagnosis of pancreatitis after endoscopic retrograde cholangiopancreatography. Surg Endosc. 2007;21:1312-1315.
24. Testoni PA, Bagnolo F. Pain at 24 hours associated with amylase levels greater than 5 times the upper normal limit as the most reliable indicator of post-ERCP pancreatitis. Gastrointest Endosc. 2001;53:33-39.
25. Hedström J, Haglund C, Haapiainen R, et al. Serum trypsinogen-2 and trypsin-2-alpha(1)-antitrypsin complex in malignant and benign digestive tract diseases: Preferential elevation in patients with cholangiocarcinomas. Int J Cancer. 1996;66:326-331.
26. Terada T, Nakanuma Y. Immunohistochemical demonstration of pancreatic alpha-amylase and trypsin in intrahepatic bile ducts and peribiliary glands. Hepatology. 1991;14:1129-1135.